"Your 2025 tax return is filed and accepted. 3 documents are awaiting your signature for the M&A engagement. Your Q1 board pack is available for download."

"This quarter delivered strong tax positioning and M&A momentum. The accelerated depreciation strategy reduced Q1 effective rate by 2.1 points. Recommend scheduling the estate planning kickoff before Q3 to capture 2026 gifting window."

"You are on track for the tax rate goal and the revenue target. The acquisition timeline is behind — Phase 2 report review is the critical path. The trust structure needs attorney action within 30 days. The EBITDA margin goal requires the pricing optimization initiative to begin this quarter — currently no action plan is assigned to it."

"The accelerated depreciation election saved $23K in Q1. The Section 199A deduction is fully optimized. Recommend exploring R&D credit study for the tech division — estimated benefit $18–32K. Augusta Rule may apply to your home office given board meeting usage."

"Revenue is tracking ahead of plan. EBITDA margin gap is primarily driven by elevated payroll in Q1 from 2 new hires — expect normalization in Q3. The AR aging balance requires attention — recommend client collection calls this week. Cash runway is healthy for the acquisition close."

"Your business entity structure provides strong baseline protection, but $4.7M remains exposed. The irrevocable trust is incomplete — your estate currently faces a potential $1.8M estate tax liability at current valuations. Life insurance has a $2M coverage gap. The succession plan has no documented timeline — a critical risk given active M&A. These three issues require immediate action before year-end."

"Assessment phase is current. Q1 diagnostic complete. Primary findings: effective tax rate 2.1 points above target, $184K AR aging risk, estate planning not yet initiated. These findings are driving the current strategy and action plan."

"6 of 9 goals are on track. The acquisition goal is at risk — Phase 2 authorization delay threatens Q3 close. Family trust formation is the most behind-schedule wealth goal with the highest time sensitivity (2026 gifting window)."

"3 active strategies are performing. 2 proposed strategies (R&D credit, Augusta Rule) are not yet approved — together worth $32–50K in estimated benefit. The CFO strategy needs updating post-acquisition close. Q2 strategy review should include an updated wealth architecture plan."

"7 open action items across the current plan. The M&A authorization and engagement letter signature are the critical path items — both are blocking Phase 2 progress. The estate planning attorney kickoff is the highest-value deferred action."

"Diagnostic last run April 3, 2026. Q2 update recommended before the June 3 strategic review. Primary finding since last diagnostic: M&A Phase 2 introduces a new tax planning requirement — acquisition structure must be determined before close to optimize step-up basis vs. carryover basis decision."

"At current EBITDA of $1.41M and a 16.2% margin, the estimated enterprise value range is $5.6M–$7.1M (4–5× EBITDA). Closing the identified value gaps — AR concentration, owner dependency, trust structure, and margin improvement — could push the target range to $7.8M–$9.9M within 18 months. The acquisition of Target Co. is the single largest near-term value catalyst."

"2 items need your input to unblock progress: the M&A engagement letter (3 days delayed) and trust attorney documents (due month end). Everything else is on schedule. 5 items completed this month — strong execution velocity."

"Firm capacity is tight in tax review and CFO reporting. Weekly output is below target by 14%. Highest leakage: underpriced cleanup tasks, excessive review cycles, delayed client responses. Recommended: rebalance reviewer workload, enforce client action deadlines, convert non-billable assessment findings into paid diagnostics."

"You are on track for the tax rate goal and the revenue target. The acquisition timeline is behind — Phase 2 report review is the critical path item. The trust structure needs attorney action within 30 days. The EBITDA margin goal requires pricing optimization to begin this quarter — currently no action plan is assigned to it."

"Your enterprise value is strong at $7.8–9.9M, driven by your niche staffing vertical specialization and advisory service mix. However, three factors are suppressing your multiple: owner revenue dependency (-0.8× impact), client concentration at 48% top-3 (a risk flag for buyers), and EBITDA margin below industry benchmarks. Addressing these three items over the next 12 months could unlock $1.8–2.4M in additional enterprise value."